glp 1 agonist benefits Frontiers GLP-1 receptor agonists and cardiovascular
Description
Brand-name pricing for tirzepatide and semaglutide will face downward pressure as more options reach market
Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, et al
Obes Sci Pract
A recent in vivo study in healthy subjects showed that acute intravenous infusion of GLP-1 during a pancreatic clamp, in which insulin and glucagon levels were maintained at basal levels, caused a reduction in hepatic glucose production, suggesting a potential direct effect on gluconeogenesis [11]
